Perturbed sex steroid status in men with idiopathic osteoporosis and their sons

被引:42
作者
Van Pottelbergh, I
Goemaere, S
Zmierczak, H
Kaufman, JM
机构
[1] Ghent Univ Hosp, Dept Endocrinol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Unit Osteoporosis & Metab Bone Dis, B-9000 Ghent, Belgium
关键词
D O I
10.1210/jc.2003-032081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We reported previously that a gender-specific defect of acquisition of lumbar bone mass plays an important role in the pathogenesis of male idiopathic osteoporosis (IO) and that there is a strong heritability of this maturational defect, which is particularly manifest in sons of men with IO. A hypothetical role of an altered sex steroid status and/or of a (TTTA)(n)-repeat polymorphism of the aromatase (CYP19) gene in male IO remains to be established. We evaluated bone mineral density (BMD) at the lumbar spine and femoral neck in 64 male IO probands (selected on the basis of a z-score of -2 or less), 21 of their sons, 41 of their brothers, and 126 healthy, age-matched controls. Serum testosterone (T), estradiol (E-2), and SHBG levels were measured by immunoassays. Free T (FT) and free E-2 (FE2) levels were calculated from total T, E-2, SHBG, and albumin concentrations using a previously validated equation. Probands, sons, and brothers had lower body weight than age-matched controls, with mean differences of 5.0, 4.6, and 4.0 kg, respectively. In probands, sons, and brothers, SHBG levels were higher compared with controls. Significantly lower FE2 levels were observed in probands and sons compared with their respective controls (P < 0.05 and P < 0.01, respectively). The brothers had nonsignificantly lower FE2 levels compared with their controls. In the total group of sons with significantly lower FE2 levels, tertile analysis according to lumbar spine BMD showed that only in the subgroup of sons belonging to the lowest tertile both FE2 and FT were decreased compared with their controls. The differences in FE2 levels in IO probands and their sons remained significant after adjustment for body mass index (BMI), even though in multivariate analyses BMI was a major determinant of BMD. The frequency distribution of the CYP19 gene (TTTA)(n)-repeat length (determined by fragment analysis, GeneScan) was not different between men with IO and their controls. In conclusion, the finding of a relative FE2 deficit in both men with IO as well as their affected sons, even after adjustment for BMI, suggests that estrogen-related perturbances may be involved in the pathogenesis of the deficient acquisition of peak bone mass in male IO.
引用
收藏
页码:4949 / 4953
页数:5
相关论文
共 30 条
[1]   HUMAN-BODY COMPOSITION AND THE EPIDEMIOLOGY OF CHRONIC DISEASE [J].
BAUMGARTNER, RN ;
HEYMSFIELD, SB ;
ROCHE, AF .
OBESITY RESEARCH, 1995, 3 (01) :73-95
[2]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95
[3]  
CARTER DR, 1992, J BONE MINER RES, V7, P137
[4]   Bone mass in middle-aged osteoporotic men and their relatives: Familial effect [J].
Cohen-Solal, ME ;
Baudoin, C ;
Omouri, M ;
Kuntz, D ;
De Vernejoul, MC .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (12) :1909-1914
[5]   Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture [J].
Evans, SF ;
Davie, MWJ .
CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (01) :9-15
[6]   Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men [J].
Gennari, L ;
Merlotti, D ;
Martini, G ;
Gonnelli, S ;
Franci, B ;
Campagna, S ;
Lucani, B ;
Dal Canto, N ;
Valenti, R ;
Gennari, C ;
Nuti, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5327-5333
[7]  
Gennari L, 2002, J BONE MINER RES, V17, pS423
[8]   Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis [J].
Gillberg, P ;
Johansson, AG ;
Ljunghall, S .
CALCIFIED TISSUE INTERNATIONAL, 1999, 64 (03) :209-213
[9]  
Haiman CA, 2000, INT J CANCER, V87, P204, DOI 10.1002/1097-0215(20000715)87:2<204::AID-IJC8>3.3.CO
[10]  
2-V